COL7A1/PI3K/AKT轴调节了胆管癌的进展情况
Yang Ma1, Yanfang Zhang1, Fangfang Chen1
1Department of General Surgery, The First Affiliated Hospital of BengBu Medical College, NO. 287, Changhuai Road, Longzihu district, Bengbu, 233000, Anhui, China.
Heliyon
|September 23, 2024
概括
第七类原体 (COL7A1) 促进胆管癌 (CCA) 细胞生长和转移. KLF4通过控制 COL7A1 表达和 PI3K/AKT 途径来调节 CCA 的进展.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 在胆管癌 (CCA) 中,原体 VII 型 (COL7A1) 的功能和分子机制尚不清楚.
- 调查COL7A1的作用对于了解CCA病原体至关重要.
研究的目的:
- 阐明COL7A1在CCA中的作用.
- 研究COL7A1在CCA中的功能背后的分子机制.
- 探索 COL7A1 和 CCA 患者预后之间的关系.
主要方法:
- 在CCA中COL7A1表达的生物信息分析.
- 定量PCR,西式涂抹和免疫组织化学检测COL7A1水平.
- 细胞增殖,迁移和入侵试验 (CCK-8,殖民地形成,Transwell).
- 路西法酶记者基因测定和细胞学实验研究KLF4-COL7A1相互作用.
- 在活体中,异种移植小鼠模型评估瘤生长.
主要成果:
- 与正常组织相比,CCA组织显示了较高的COL7A1表达.
- COL7A1敲除显著抑制了CCA细胞的增殖,迁移和入侵.
- COL7A1的淘汰抑制了PI3K/AKT信号通路.
- 发现KLF4可以结合和调节COL7A1的表达,从而影响PI3K/AKT通路.
结论:
- KLF4通过COL7A1/PI3K/AKT信号轴调节CCA细胞的增殖,迁移和入侵.
- COL7A1是CCA进展的关键调解者,由KLF4.4调节.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K


